semaglutide compounds banned Replica Ozempic and Mounjaro will be by October The FDA Is Reconsidering Its

Additionally, those taking semaglutide also showed a 9% reduction in the pace of biological aging, as measured by the DunedinPACE clock, and significant improvements in markers linked to all-cause mortality risk and age-related disease, as measured by the PCGrimAge clock

17 BrittonRAHoffmannDEKhorutsA

it is disadvantageous to decrease muscle mass and associated energy expenditure during weight loss efforts that rely on caloric restriction

The table below compares the two approaches at a glance

Regulatory status and what comes next As of the date of publication, CagriSema has not received regulatory approval from any major health authority, including the MHRA (UK), EMA (Europe), or FDA (United States)